Some 3 years ago we first commented on a Phase II trial of a drug now called topsalycin (but then known as PRX302) in the treatment of low- to intermediate-risk, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Leave a comment »
A newly published paper on the development of prostate cancer in patients of ≤ 55 years of age claims to have shown that
Using a newly-developed computer model, it is now possible to predict the course of the disease in individual patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Diagnosis, genomics, medicine, modeling, personalized, prognosis | 2 Comments »
In this week’s issue of the New England Journal of Medicine, Bill-Axelson et al. offer data from a sixth update to the outcomes from the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) trial of radical prostatectomy vs. watchful waiting … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | 1 Comment »
We finally have some published data — albeit not a lot — on the use of one of the PD-1 inhibitors (pembrolizumab, also known as Keytruda) in the treatment of late-stage prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: activity, efficacy, Keytruda, outcome, pembrolizumab, safety, trial | 4 Comments »
Perhaps understandably, the average prostate cancer patient seems to be less exercise willing than he thinks (and reports that) he is — but it’s not all bad news! … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | 2 Comments »
A newly published report in European Urology has suggested that men who have inflammatory bowel disease (IBD) — either Crohn’s disease or ulcerative colitis — are at a significantly increased risk for prostate cancer over time. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: bowel, colitis, Crohn's, disease, IBD, inflammatory, ulcerative | Leave a comment »
